Impact BioMedical Inc. Files S-1/A Amendment

TL;DR

IMPACT files S-1/A amendment, watch for future stock moves.

AI Summary

Impact BioMedical Inc. filed an S-1/A amendment on August 27, 2024, for its registration statement. The filing, with registration number 333-275062, pertains to the company's securities and is an amendment to a previous filing. The company is incorporated in Nevada and its principal executive offices are located in Houston, Texas.

Why It Matters

This filing indicates ongoing regulatory activity and potential future stock offerings or changes in the company's securities structure, which could impact investors.

Risk Assessment

Risk Level: medium — S-1/A filings often precede significant corporate actions like stock offerings, which carry inherent market risks.

Key Numbers

• 333-275062 — SEC File Number (Identifies the specific registration filing with the SEC.)

Key Players & Entities

• Impact BioMedical Inc. (company) — Registrant
• August 27, 2024 (date) — Filing Date
• 333-275062 (registration_number) — SEC File Number
• Nevada (jurisdiction) — State of Incorporation
• Houston, TX (location) — Principal Executive Offices
• Frank D. Heuszel (person) — Chief Executive Officer
• Darrin M. Ocasio, Esq. (person) — Legal Counsel
• Joseph M. Lucosky, Esq. (person) — Legal Counsel

FAQ

Filing Documents

• forms-1a.htm (S-1/A) — 64KB
• 0001493152-24-034009.txt ( ) — 65KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the town of West Henrietta, New York on the 27 th day of August 2024. IMPACT BIOMEDICAL INC. By: /s/ Frank D. Heuszel Name: Frank D. Heuszel Title: President Dated: August 27, 2024 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Frank D. Heuszel, as his true and lawful attorney-in-fact and agent with full power of substitution, for him in any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments or any abbreviated registration statement and any amendments thereto filed pursuant to Rule 462(b) increasing the number of securities for which registration is sought), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact, proxy and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, proxy and agent, or his substitute, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, this registration statement on Form S-1 has been signed by the following persons in the capacities and on the dates indicated. Signature Title Date /s/ Frank D. Heuszel Frank D. Heuszel Chairman of the Board, Chief Executive Officer (Principal Executive Officer) and President August 27, 2024 /s/ Jason Grady Jason Grady Director August 27, 2024 /s/ Todd D. Macko Todd D. Macko Chief Financial Officer (Principal F

View Full Filing

View this S-1/A filing on SEC EDGAR